Karyopharm Therapeutics | KPTI - Action





Action Changement Date
AbbVie USD 5.05B 98M 2026-03
Abbott USD 6.99B 501M 2026-03
Amgen USD 6.19B 39M 2026-03
AstraZeneca USD 6.57B 13M 2026-03
BioCryst Pharmaceuticals USD 5.98M 587K 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Eli Lilly USD 14.53B 785M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Incyte USD 115.62M 14.56M 2026-03
J&J USD 14.58B 392M 2026-03
Karyopharm Therapeutics USD 4.04M 72K 2025-12
MacroGenics USD 9.5M 1.59M 2026-03
Merck USD 6.48B 179M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.29B 17M 2026-03
Novartis USD 6.29B 135M 2026-03
Pfizer USD 10.67B 13M 2026-03
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Takeda JPY 1.41T 107.71B 2025-12
TG Therapeutics USD 129.03M 3.44M 2026-03
Ultragenyx Pharmaceutical USD 55M 3M 2026-03